As incorporating Real World Evidence (RWE) in Health Economics and Outcomes Research (HEOR) strategy is gaining attention within the life sciences, and pharma in particular, global research organizations need to learn how to navigate the complexities of gathering and analyzing this data to demonstrate product value.
Mary Beth Ritchey, PhD
RTI Health Solutions
Some questions that will be answered include:
- What is RWE and HEOR?
- What are some of the major challenges when sourcing HEOR and RWE?
- What sourcing trends are occurring in the global strategy and regulation of RWE (including HEOR, epidemiology, market access and other RWE)?
- What are the best practices and strategies when sourcing HEOR and RWE services?
For more information or to register for this event, visit HEOR & RWE: Global Sourcing Strategies and Best Practices.